Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 442

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1B
Chunk 442
---
 (823)
  
    Total general and administration expenses 
     (13,128) 
     (17,174)

F-17

Note 12 - Stock-based payments

    June 30, 2025  
    June 30, 2024 

    (in thousands) 
  
    Research and development 
     -  
     - 
  
    General and administrative 
     (2,609) 
     (8,928)
  
    Total stock-based compensation expense 
     (2,609) 
     (8,928)

Restricted stocks

A summary of the changes in the Company’s
restricted stock activity for the fiscal year ended June 30, 2025, are as follows:

    Numbers of
 Shares  
    Weighted
 Average
 Grant Date
 Fair Value
 $ 
  
    Unvested and Outstanding as of June 30, 2024 
     651,939  
     3.91 
  
    Granted 
     40,739,093  
     0.23 
  
    Vested 
     (623,984) 
     3.97 
  
    Forfeited 
     -  
     - 
  
    Unvested and Outstanding as of June 30, 2025 
     40,767,047  
     0.23 

Stock Options

A summary of the changes in the Company’s
stock options activity for the fiscal year ended June 30, 2025, are as follows:

     Numbers of Shares   Weighted Average Exercise Price ($)   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value 
(in thousands) ($)   Unvested and Outstanding as of June 30, 2024   235,008    26.76    1.93           -   Granted   -    -    -    -   Vested   -    -    -    -   Forfeited   (7,500)   3.28    -    -   Outstanding as of June 30, 2025   227,508    27.22    1.46    -   Unvested as of June 30,